title: [Morphologically unfavorable forms of lupus glomerulonephritis: treatment and prognosis].
authors.forename: E V
authors.initials: EV
authors.lastname: Zakharova
authors.forename: N A
authors.initials: NA
authors.lastname: Mikhaĭlova
authors.forename: V M
authors.initials: VM
authors.lastname: Ermolenko
authors.forename: I I
authors.initials: II
authors.lastname: Gabdurakhmanov
authors.forename: V A
authors.initials: VA
authors.lastname: Varshavskiĭ
authors.forename: E P
authors.initials: EP
authors.lastname: Proskurneva
mesh_terms: D000293:Adolescent; D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000328:Adult; D000925:Anticoagulants / Q000627:therapeutic use; D001707:Biopsy, Needle; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007672:Kidney Cortex / Q000473:pathology*; D008181:Lupus Nephritis / Q000175:diagnosis / Q000188:drug therapy* / Q000473:pathology; D008297:Male; D008875:Middle Aged; D011379:Prognosis; D016896:Treatment Outcome
chemical_list: D000305:Adrenal Cortex Hormones; D000925:Anticoagulants; D007166:Immunosuppressive Agents